Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan

Background We examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35 year period. Methods We collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics international 2015-08, Vol.57 (4), p.650-655
Hauptverfasser: Kawasaki, Yukihiko, Ohara, Shinichiro, Miyazaki, Kyohei, Kanno, Shuto, Ono, Atsushi, Suyama, Kazuhide, Sato, Masatoki, Suzuki, Shigeo, Maeda, Ryo, Nagasawa, Katsutoshi, Hosoya, Mitsuaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 655
container_issue 4
container_start_page 650
container_title Pediatrics international
container_volume 57
creator Kawasaki, Yukihiko
Ohara, Shinichiro
Miyazaki, Kyohei
Kanno, Shuto
Ono, Atsushi
Suyama, Kazuhide
Sato, Masatoki
Suzuki, Shigeo
Maeda, Ryo
Nagasawa, Katsutoshi
Hosoya, Mitsuaki
description Background We examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35 year period. Methods We collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were divided into two groups. group 1 consisted of 19 patients who were diagnosed between 1977 and 1995, and group 2 consisted of 18 patients diagnosed between 1996 and 2013. The epidemiology, clinical features, and prognosis were retrospectively compared between the two groups. Results The mean number of patients per 100 000 children per year for group 1 and group 2 was 0.33 ± 0.25 and 0.35 ± 0.30, respectively. The duration from onset of symptoms to treatment in group 2 was shorter than that in group 1, but the clinical and laboratory findings at onset did not differ between the two groups. All patients were treated with prednisolone, and 17 patients in group 1 and 18 in group 2 were treated with methylprednisolone pulse therapy. The frequency of cyclophosphamide treatment decreased whereas the frequency of cyclosporine, tacrolimus and mizoribine pulse therapy increased in group 2. SLE disease activity index (SLEDAI) score at the latest follow up in group 2 was lower in group 1. The survival rate was 84% in group 1 and 100% in group 2. Conclusion The frequency and severity of SLE in group 1 were similar to those in group 2, and the prognosis of SLE in group 2 was better than that in group 1.
doi_str_mv 10.1111/ped.12588
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1708161553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1708161553</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3298-98a3035b9ca6f95b3f644b92ab402b3cda2f707bc2f3d8ef5af2d23cd899de643</originalsourceid><addsrcrecordid>eNo9kMlOwzAURS0EYigs-AHkJQvSeogTe4lKgVYVUAGCneXEDhgyETeC7Njym3wJ7kC98XvP9z75HgCOMepjfwa10X1MGOdbYB-HIQkIQs_bvqaEBxxF8R44cO4NIcRjHu6CPcIizAQV-0CNy9RqU6YGqlLDuqleyspZB6sMus7NTWFTmLd166BpuvmrKdS8cr6zJVSQst_vn86oBtamsZVeTC_b99a92kKdwYmqVXkIdjKVO3O0vnvg8XL0MLwOprdX4-H5NLCUCB4IriiiLBGpijLBEppFYZgIopIQkYSmWpEsRnGSkoxqbjKmMqKJn3MhtIlC2gOnq70-w0dr3FwW1qUmz1VpqtZJHCOOfWxGvfRkLW2TwmhZN_67TSf_sXjBYCX4tLnpNu8YyQVv6XnLJW95N7pYFt4RrBzWM_vaOFTzLqOYxkw-3VzJezychrPhTE7oH3oWgwc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708161553</pqid></control><display><type>article</type><title>Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kawasaki, Yukihiko ; Ohara, Shinichiro ; Miyazaki, Kyohei ; Kanno, Shuto ; Ono, Atsushi ; Suyama, Kazuhide ; Sato, Masatoki ; Suzuki, Shigeo ; Maeda, Ryo ; Nagasawa, Katsutoshi ; Hosoya, Mitsuaki</creator><creatorcontrib>Kawasaki, Yukihiko ; Ohara, Shinichiro ; Miyazaki, Kyohei ; Kanno, Shuto ; Ono, Atsushi ; Suyama, Kazuhide ; Sato, Masatoki ; Suzuki, Shigeo ; Maeda, Ryo ; Nagasawa, Katsutoshi ; Hosoya, Mitsuaki</creatorcontrib><description>Background We examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35 year period. Methods We collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were divided into two groups. group 1 consisted of 19 patients who were diagnosed between 1977 and 1995, and group 2 consisted of 18 patients diagnosed between 1996 and 2013. The epidemiology, clinical features, and prognosis were retrospectively compared between the two groups. Results The mean number of patients per 100 000 children per year for group 1 and group 2 was 0.33 ± 0.25 and 0.35 ± 0.30, respectively. The duration from onset of symptoms to treatment in group 2 was shorter than that in group 1, but the clinical and laboratory findings at onset did not differ between the two groups. All patients were treated with prednisolone, and 17 patients in group 1 and 18 in group 2 were treated with methylprednisolone pulse therapy. The frequency of cyclophosphamide treatment decreased whereas the frequency of cyclosporine, tacrolimus and mizoribine pulse therapy increased in group 2. SLE disease activity index (SLEDAI) score at the latest follow up in group 2 was lower in group 1. The survival rate was 84% in group 1 and 100% in group 2. Conclusion The frequency and severity of SLE in group 1 were similar to those in group 2, and the prognosis of SLE in group 2 was better than that in group 1.</description><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.12588</identifier><identifier>PMID: 25615939</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Age of Onset ; Biopsy ; Bredinin ; Child ; clinical manifestation ; epidemiology ; Female ; Follow-Up Studies ; Forecasting ; Humans ; Incidence ; Japan - epidemiology ; Lupus Erythematosus, Systemic - diagnosis ; Lupus Erythematosus, Systemic - epidemiology ; Male ; methylprednisolone ; Retrospective Studies ; Severity of Illness Index ; Survival Rate - trends ; systemic lupus erythematosus</subject><ispartof>Pediatrics international, 2015-08, Vol.57 (4), p.650-655</ispartof><rights>2015 Japan Pediatric Society</rights><rights>2015 Japan Pediatric Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fped.12588$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fped.12588$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25615939$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawasaki, Yukihiko</creatorcontrib><creatorcontrib>Ohara, Shinichiro</creatorcontrib><creatorcontrib>Miyazaki, Kyohei</creatorcontrib><creatorcontrib>Kanno, Shuto</creatorcontrib><creatorcontrib>Ono, Atsushi</creatorcontrib><creatorcontrib>Suyama, Kazuhide</creatorcontrib><creatorcontrib>Sato, Masatoki</creatorcontrib><creatorcontrib>Suzuki, Shigeo</creatorcontrib><creatorcontrib>Maeda, Ryo</creatorcontrib><creatorcontrib>Nagasawa, Katsutoshi</creatorcontrib><creatorcontrib>Hosoya, Mitsuaki</creatorcontrib><title>Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan</title><title>Pediatrics international</title><addtitle>Pediatr Int</addtitle><description>Background We examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35 year period. Methods We collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were divided into two groups. group 1 consisted of 19 patients who were diagnosed between 1977 and 1995, and group 2 consisted of 18 patients diagnosed between 1996 and 2013. The epidemiology, clinical features, and prognosis were retrospectively compared between the two groups. Results The mean number of patients per 100 000 children per year for group 1 and group 2 was 0.33 ± 0.25 and 0.35 ± 0.30, respectively. The duration from onset of symptoms to treatment in group 2 was shorter than that in group 1, but the clinical and laboratory findings at onset did not differ between the two groups. All patients were treated with prednisolone, and 17 patients in group 1 and 18 in group 2 were treated with methylprednisolone pulse therapy. The frequency of cyclophosphamide treatment decreased whereas the frequency of cyclosporine, tacrolimus and mizoribine pulse therapy increased in group 2. SLE disease activity index (SLEDAI) score at the latest follow up in group 2 was lower in group 1. The survival rate was 84% in group 1 and 100% in group 2. Conclusion The frequency and severity of SLE in group 1 were similar to those in group 2, and the prognosis of SLE in group 2 was better than that in group 1.</description><subject>Age of Onset</subject><subject>Biopsy</subject><subject>Bredinin</subject><subject>Child</subject><subject>clinical manifestation</subject><subject>epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Forecasting</subject><subject>Humans</subject><subject>Incidence</subject><subject>Japan - epidemiology</subject><subject>Lupus Erythematosus, Systemic - diagnosis</subject><subject>Lupus Erythematosus, Systemic - epidemiology</subject><subject>Male</subject><subject>methylprednisolone</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Survival Rate - trends</subject><subject>systemic lupus erythematosus</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMlOwzAURS0EYigs-AHkJQvSeogTe4lKgVYVUAGCneXEDhgyETeC7Njym3wJ7kC98XvP9z75HgCOMepjfwa10X1MGOdbYB-HIQkIQs_bvqaEBxxF8R44cO4NIcRjHu6CPcIizAQV-0CNy9RqU6YGqlLDuqleyspZB6sMus7NTWFTmLd166BpuvmrKdS8cr6zJVSQst_vn86oBtamsZVeTC_b99a92kKdwYmqVXkIdjKVO3O0vnvg8XL0MLwOprdX4-H5NLCUCB4IriiiLBGpijLBEppFYZgIopIQkYSmWpEsRnGSkoxqbjKmMqKJn3MhtIlC2gOnq70-w0dr3FwW1qUmz1VpqtZJHCOOfWxGvfRkLW2TwmhZN_67TSf_sXjBYCX4tLnpNu8YyQVv6XnLJW95N7pYFt4RrBzWM_vaOFTzLqOYxkw-3VzJezychrPhTE7oH3oWgwc</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Kawasaki, Yukihiko</creator><creator>Ohara, Shinichiro</creator><creator>Miyazaki, Kyohei</creator><creator>Kanno, Shuto</creator><creator>Ono, Atsushi</creator><creator>Suyama, Kazuhide</creator><creator>Sato, Masatoki</creator><creator>Suzuki, Shigeo</creator><creator>Maeda, Ryo</creator><creator>Nagasawa, Katsutoshi</creator><creator>Hosoya, Mitsuaki</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201508</creationdate><title>Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan</title><author>Kawasaki, Yukihiko ; Ohara, Shinichiro ; Miyazaki, Kyohei ; Kanno, Shuto ; Ono, Atsushi ; Suyama, Kazuhide ; Sato, Masatoki ; Suzuki, Shigeo ; Maeda, Ryo ; Nagasawa, Katsutoshi ; Hosoya, Mitsuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3298-98a3035b9ca6f95b3f644b92ab402b3cda2f707bc2f3d8ef5af2d23cd899de643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age of Onset</topic><topic>Biopsy</topic><topic>Bredinin</topic><topic>Child</topic><topic>clinical manifestation</topic><topic>epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Forecasting</topic><topic>Humans</topic><topic>Incidence</topic><topic>Japan - epidemiology</topic><topic>Lupus Erythematosus, Systemic - diagnosis</topic><topic>Lupus Erythematosus, Systemic - epidemiology</topic><topic>Male</topic><topic>methylprednisolone</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Survival Rate - trends</topic><topic>systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawasaki, Yukihiko</creatorcontrib><creatorcontrib>Ohara, Shinichiro</creatorcontrib><creatorcontrib>Miyazaki, Kyohei</creatorcontrib><creatorcontrib>Kanno, Shuto</creatorcontrib><creatorcontrib>Ono, Atsushi</creatorcontrib><creatorcontrib>Suyama, Kazuhide</creatorcontrib><creatorcontrib>Sato, Masatoki</creatorcontrib><creatorcontrib>Suzuki, Shigeo</creatorcontrib><creatorcontrib>Maeda, Ryo</creatorcontrib><creatorcontrib>Nagasawa, Katsutoshi</creatorcontrib><creatorcontrib>Hosoya, Mitsuaki</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawasaki, Yukihiko</au><au>Ohara, Shinichiro</au><au>Miyazaki, Kyohei</au><au>Kanno, Shuto</au><au>Ono, Atsushi</au><au>Suyama, Kazuhide</au><au>Sato, Masatoki</au><au>Suzuki, Shigeo</au><au>Maeda, Ryo</au><au>Nagasawa, Katsutoshi</au><au>Hosoya, Mitsuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan</atitle><jtitle>Pediatrics international</jtitle><addtitle>Pediatr Int</addtitle><date>2015-08</date><risdate>2015</risdate><volume>57</volume><issue>4</issue><spage>650</spage><epage>655</epage><pages>650-655</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><abstract>Background We examined the epidemiology, clinical manifestations, and prognosis of pediatric systemic lupus erythematosus (SLE) in Fukushima Prefecture, Japan over a 35 year period. Methods We collected the medical records of 37 patients diagnosed with SLE between 1977 and 2013. These children were divided into two groups. group 1 consisted of 19 patients who were diagnosed between 1977 and 1995, and group 2 consisted of 18 patients diagnosed between 1996 and 2013. The epidemiology, clinical features, and prognosis were retrospectively compared between the two groups. Results The mean number of patients per 100 000 children per year for group 1 and group 2 was 0.33 ± 0.25 and 0.35 ± 0.30, respectively. The duration from onset of symptoms to treatment in group 2 was shorter than that in group 1, but the clinical and laboratory findings at onset did not differ between the two groups. All patients were treated with prednisolone, and 17 patients in group 1 and 18 in group 2 were treated with methylprednisolone pulse therapy. The frequency of cyclophosphamide treatment decreased whereas the frequency of cyclosporine, tacrolimus and mizoribine pulse therapy increased in group 2. SLE disease activity index (SLEDAI) score at the latest follow up in group 2 was lower in group 1. The survival rate was 84% in group 1 and 100% in group 2. Conclusion The frequency and severity of SLE in group 1 were similar to those in group 2, and the prognosis of SLE in group 2 was better than that in group 1.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25615939</pmid><doi>10.1111/ped.12588</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1328-8067
ispartof Pediatrics international, 2015-08, Vol.57 (4), p.650-655
issn 1328-8067
1442-200X
language eng
recordid cdi_proquest_miscellaneous_1708161553
source MEDLINE; Access via Wiley Online Library
subjects Age of Onset
Biopsy
Bredinin
Child
clinical manifestation
epidemiology
Female
Follow-Up Studies
Forecasting
Humans
Incidence
Japan - epidemiology
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - epidemiology
Male
methylprednisolone
Retrospective Studies
Severity of Illness Index
Survival Rate - trends
systemic lupus erythematosus
title Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T06%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20prognosis%20of%20systemic%20lupus%20erythematosus%20in%20a%2035%E2%80%89year%20period%20in%20Fukushima,%20Japan&rft.jtitle=Pediatrics%20international&rft.au=Kawasaki,%20Yukihiko&rft.date=2015-08&rft.volume=57&rft.issue=4&rft.spage=650&rft.epage=655&rft.pages=650-655&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.12588&rft_dat=%3Cproquest_pubme%3E1708161553%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1708161553&rft_id=info:pmid/25615939&rfr_iscdi=true